22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release
here
Home
About Us
Our Company
Our Leadership Team
Board of Directors
Reduced Nicotine Tobacco
VLN®
Clinical Studies & Commentaries
Hemp/Cannabis Innovation
GVB Biopharma
Hops Research
News
Investors
Overview
New Investor / Latest Resources
Events
News
Stock Data
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Contact Us
Corporate Governance
Investors
Investors
Overview
New Investor / Latest Resources
Events
News
Press Releases
Stock Data
Quote
Charts
Historical Data
Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Code of Business Conduct and Corporate Ethics
Download
Code of Business Conduct and Corporate Ethics
Insider Trading Policy
Download
Insider Trading Policy
Audit Committee Charter
Download
Audit Committee Charter
Compensation Committee Charter
Download
Compensation Committee Charter
Corporate Governance & Nominating Committee Charter
Download
Corporate Governance & Nominating Committee Charter
Environmental, Social, and Governance Policy
Download
Environmental, Social, and Governance Policy
Finance Committee Charter
Download
Finance Committee Charter
Scientific Advisory Board
Download
Scientific Advisory Board
Regulation Fair Disclosure (Reg FD)
Download
Regulation Fair Disclosure (Reg FD)
Email Alerts
Contact
RSS News Feed